权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

SC COBRE for Translational Research Improving Musculoskeletal Health (SC-TRIMH)

SC COBRE 用于改善肌肉骨骼健康的转化研究 (SC-TRIMH)

基本信息

批准号：
10400367
负责人：
Hai Yao
金额：
$ 24.82万
依托单位：
CLEMSON UNIVERSITY
依托单位国家：
美国
项目类别：
财政年份：
2018
资助国家：
美国
起止时间：
2018-09-15 至 2023-07-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/10400367
关键词：
Advisory Committees Animal Model Animal Testing Animals Area Award Basic Science Bioinformatics Biology Biomedical Engineering Biomedical Research Bone Diseases Cadaver Centers of Research Excellence Clinical Collaborations Communities Complement Computer Models Data Development Devices Discipline Evaluation Faculty Faculty Recruitment Fostering Funding Future Glossary Goals Health Health system Healthcare Human Infrastructure Intervention Investments Medical Medical Research Medicine Mentors Modeling Modernization Musculoskeletal Musculoskeletal Diseases Musculoskeletal System Nature Outcome Patients Performance Personnel Recruitments Physics Precision therapeutics Private Sector Process Public Health Publishing Randomized Clinical Trials Research Research Infrastructure Research Personnel Resources Schools Shapes South Carolina Specimen Supercomputing Systems Biology Technology Technology Transfer Testing Therapeutic Therapeutic Intervention Therapeutic Uses Time Tissues Training Translating Translational Research Translations United States United States National Institutes of Health Universities Validation Work acronyms aging population arthropathies base body system career clinical practice cluster computing cost disability equipment acquisition flexibility improved in vivo innovation interdisciplinary approach interest materials science multi-scale modeling multidisciplinary novel novel strategies novel therapeutic intervention pre-clinical assessment precision medicine programs sensor technology skeletal success systems research technology development virtual human

项目摘要

SUMMARY The overall goal of the South Carolina COBRE for Translational Research Improving Musculoskeletal Health (SC-TRIMH) is to enhance and expand the Biomedical Research capacity at Clemson University to promote outstanding multidisciplinary, collaborative, and translational research in bone and joint diseases. A new scientific concept for translational research, i.e. Virtual Human Trials, is to be implemented through powerful computational modeling combined with quantitative functional validation and assessment to expedite the process from concept development to deliverable new therapeutics, interventions, and devices for musculoskeletal health. A multidisciplinary and interactive center to promote translational research for musculoskeletal health is to be developed by supporting junior investigators and enhancing their research competitiveness. The specific aims are to: 1) train and mentor an initial cadre of five targeted junior investigators to develop independent NIH funded research careers in musculoskeletal health research; 2) develop and enhance key areas of research infrastructure through the development of novel cores and enhancement of existing ones, which serve as platforms to increase the potential of the targeted faculty to compete successfully for NIH funding and forge collaborative ties with investigators statewide with relevant research interests; 3) promote the long-term viability of SC-TRIMH through technology transfer as well as rigorous evaluation and improvement strategies. The Center is led by a multidisciplinary team with expertise in physics, material science, computing, bioengineering, public health, biology, and medicine, thereby coalescing resources and disciplines from Clemson University School of Health Research (CUSHR) and allied with Greenville Health System (GHS). Scientific cores include: 1) Multi-scale Computational Modeling Core to utilize cluster computing, bioinformatics, and systems biology to model patient/specimen specific musculoskeletal system at body, tissue, and cellular levels for the development of novel skeletal devices, interventions, and therapeutics for precision medicine; 2) Advanced Fabrication and Testing Core to generate, refine, and optimize the function and performance of devices, interventions, and therapeutics using the advanced micro and macro fabrication technologies; 3) Preclinical Assessment Core to provide animal testing and human cadaver analysis to assess the in vivo function of novel devices, interventions, and therapeutics. These cores will enable the initial 5 junior investigator projects to implement the new concept of Virtual Human Trials to advance musculoskeletal health and facilitate their competitiveness for national research awards. Extensive institutional support – including flexible funds, new faculty recruitment and major equipment purchase – will underwrite the Center's long-term success and viability. This initiative capitalizes on the existing infrastructure at Clemson University, CUSHR, and its innovation hub at GHS.

总结